Edoxaban

Green-G

Brand Name(s):

Indication:Deep vein thrombosis (DVT) and pulmonary embolism (PE) – treatment & prevention of recurrence
Stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation with one or more risk factors – prevention of

Rationale:

Considered:Jul-15

Review Date:Jul-24

Comments:
Non Formulary item
…………………………
Drug Safety Update
Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome
June 19
…………………………
NICE TA355
Edoxaban for preventing stroke and systemic embolism in people with non valvular atrial fibrillation
https://www.nice.org.uk/guidance/ta355/resources/edoxaban-for-preventing-stroke-and-systemic-embolism-in-people-with-nonvalvular-atrial-fibrillation-82602669987781
Sept 2015